Brind.

Michael Denzer's career path includes pivotal roles at Bristol Myers Squibb, Amgen, and Teva, with his most recent company being Civica.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Bristol-Myers Squibb Amgen Civica Teva Pharmaceutical Industries Ltd.

Keep exploring

The entities involved

Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Civica
international software business group

Nothing else this week.
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
- Teva Pharmaceutical Industries Ltd. is being investigated by the Competition Authority regarding generic competition practices.Mon 13:16
- Leerink partners issued an 'outperform' rating on Teva stock, while an insider sold shares of the company.Wed 01:19

Coverage

Newest first; wire copies grouped

Jul 21Business WireEdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate Product Innovation and Client Partnerships WHEELING, Ill., July 21, 2025--(BUSINESS WIRE)--EdgeOne M